| abstract |
Method for in vitro diagnosis or prognosis of the tolerance status of a patient undergoing a liver transplant comprising: a. Measurement, in a biological sample obtained from the hepatic allograft of the patient under investigation, of the expression levels of at least one of the following genes or combinations thereof: TFRC, CDHR2, HMOX1, MIF, HAMP, IFNG, PEBP1, SLC5A12, ADORA3 and DAB2; b. Evaluation of the tolerance or non-tolerance of the patient under investigation for liver transplantation by comparing the level of expression of at least one of the genes or combinations thereof, from step a), with the level of expression of the same genes or combinations of the same, obtained from a reference sample. |